Correlation Between Pacira BioSciences, and Bausch Health

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pacira BioSciences, and Bausch Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pacira BioSciences, and Bausch Health into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pacira BioSciences, and Bausch Health Companies, you can compare the effects of market volatilities on Pacira BioSciences, and Bausch Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pacira BioSciences, with a short position of Bausch Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pacira BioSciences, and Bausch Health.

Diversification Opportunities for Pacira BioSciences, and Bausch Health

0.66
  Correlation Coefficient

Poor diversification

The 3 months correlation between Pacira and Bausch is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Pacira BioSciences, and Bausch Health Companies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bausch Health Companies and Pacira BioSciences, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pacira BioSciences, are associated (or correlated) with Bausch Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bausch Health Companies has no effect on the direction of Pacira BioSciences, i.e., Pacira BioSciences, and Bausch Health go up and down completely randomly.

Pair Corralation between Pacira BioSciences, and Bausch Health

Given the investment horizon of 90 days Pacira BioSciences, is expected to under-perform the Bausch Health. But the stock apears to be less risky and, when comparing its historical volatility, Pacira BioSciences, is 1.05 times less risky than Bausch Health. The stock trades about -0.03 of its potential returns per unit of risk. The Bausch Health Companies is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  786.00  in Bausch Health Companies on September 4, 2024 and sell it today you would lose (4.00) from holding Bausch Health Companies or give up 0.51% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Pacira BioSciences,  vs.  Bausch Health Companies

 Performance 
       Timeline  
Pacira BioSciences, 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Pacira BioSciences, are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Pacira BioSciences, showed solid returns over the last few months and may actually be approaching a breakup point.
Bausch Health Companies 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Bausch Health Companies are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain technical indicators, Bausch Health exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pacira BioSciences, and Bausch Health Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pacira BioSciences, and Bausch Health

The main advantage of trading using opposite Pacira BioSciences, and Bausch Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pacira BioSciences, position performs unexpectedly, Bausch Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bausch Health will offset losses from the drop in Bausch Health's long position.
The idea behind Pacira BioSciences, and Bausch Health Companies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Other Complementary Tools

Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges